From different corners of the cancer journey, Lori Gilman and Dr. Mitchel Hoffman exemplify how modern medicine, genetic ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...

Fact checked by Nick Blackmer Some companies now offer multi-cancer early detection tests designed to screen for multiple ...

He called and he said, ‘I’ve got the CT scan results, and it’s not diverticulitis, it’s cancer,’” Barr said, adding the scan ...